Onicoma®

Efinaconazole INN

Prescribing Details



Description

Onicoma is a preparation of Efinaconazole which is an azole antifungal. Efinaconazole inhibits fungal lanosterol 14α-demethylase involved in the biosynthesis of ergosterol, a constituent of fungal cell membranes.


Uses

No Data


Indications

Onicoma is indicated for the treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes


Dosage and administration

Onicoma is for topical use only. Apply this solution to affected toenails once daily for 48 weeks, using the integrated flow-through brush applicator. When applying it, ensure the toenail, the toenail folds, toenail bed, hyponychium, and the undersurface of the toenail plate, are completely covered.


Use in pregnancy & lactation

Pregnancy: There are no available human data for the use of this solution
during pregnancy to inform any drug associated risks of major birth defects,
miscarriage, or adverse maternal or fetal outcomes.


Lactation: It is not known whether efinaconazole is excreted in human milk.
Because many drugs are excreted in human milk, caution should be exercised
when this solution is administered to nursing women.

 

Use in children and adolescents

Safety and effectiveness of efinaconazole solution in pediatric patients under 6
years of age have not been established


Geriatric use
No Data

Precautions

Efinaconazole is for topical use only and not for oral, ophthalmic or intravaginal use. If the area of application shows signs of persistent irritation (for example, redness, itching, swelling), stop the use of this solution. This solution is flammable, avoid use near heat or open flame.


Side effects

The most common side effects are ingrown toenails, application site dermatitis, application site vesicles and application site pain


Contraindications

It is contraindicated in patients with known hypersensitivity to efinaconazole or any other components of this product.


Drug interactions

Drug interaction with medication: This solution, at therapeutic concentrations,
neither inhibits nor induces cytochrome P450 (CYP450) enzymes.


Drug interaction with food and others: Not applicable.


Overdose

There have been no reported sequelae in patients who have received significantly more efinaconazole solution than the recommended dosage.


Preparation

No Data


Pharmaceutical precautions

No Data


Presentation

No Data


Package quantities

Storage
Store in a cool (below 30ºC) & dry place protected from light. Keep out of the
reach of children.


Packing
Onicoma Topical Solution 10%: Plastic bottle of 8 ml.